General MedicationsINJECTIONStandard
GANIRELIX ACETATE
GANIRELIX ACETATE
Standard Dose
250MCG/0.5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview GANIRELIX ACETATE is listed in Drugs@FDA under application 219454 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient GANIRELIX ACETATE Form and strength INJECTABLE;INJECTION - 250MCG/0.5ML Sponsor TRIS PHARMA INC Submission history Latest submission status date: 2025-06-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview GANIRELIX ACETATE is listed in Drugs@FDA under application 219454 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient GANIRELIX ACETATE Form and strength INJECTABLE;INJECTION - 250MCG/0.5ML Sponsor TRIS PHARMA INC Submission history Latest submission status date: 2025-06-27 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.